Stocks News

LAST PRICE
179.1100
TODAY'S CHANGE (%)
Trending Down-0.9600 (-0.5331%)

Bid / Lots
179.0400/ 4
Ask / Lots
179.4000/ 1
Open / Previous Close
180.3300 / 180.0700
Day Range
Low 177.9348
High 181.6800
52 Week Range
Low 125.8200
High 298.9500
Volume
70,606
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Insulet to Present at the Jefferies Global Healthcare Conference, from 5 hours ago by Business Wire
  5 hours ago by Business Wire
  Companies Mentioned: PODD
  Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod(R) brand of products, today announced that management will present at the Jefferies Global Healthcare Conference in New York City on Thursday, June 6, 2024 at 9:00 a.m. (Eastern Time).
- Insulet to Present at the Jefferies Global Healthcare Conference, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: PODD
  ACTON, Mass.--(BUSINESS WIRE)--May 28, 2024--
  Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod(R) brand of products, today announced that management will present at the Jefferies Global Healthcare Conference in New York City on Thursday, June 6, 2024 at 9:00 a.m. (Eastern Time).
May 14, 2024
- Insulet Shares Rise Despite Blue Orca's Short Position, from 11:19AM ET on Tuesday May 14, 2024 by MT Newswires
  11:19AM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: PODD
  11:19 AM EDT, 05/14/2024 (MT Newswires) -- Insulet (PODD) shares were advancing by 5.7% in recent Tuesday trading despite short-seller Blue Orca Capital saying it had taken a short position on the stock. The firm alleged in a report that Insulet has...
May 13, 2024
- DJ Insulet Is Maintained at Equal-Weight by Barclays, from 2:14PM ET on Monday May 13, 2024 by Dow Jones
  2:14PM ET on Monday May 13, 2024 by Dow Jones
  Companies Mentioned: PODD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/PODD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 13, 2024 14:14 ET (18:14 GMT)
May 10, 2024
- DJ Insulet Is Maintained at Buy by Canaccord Genuity, from 2:55PM ET on Friday May 10, 2024 by Dow Jones
  2:55PM ET on Friday May 10, 2024 by Dow Jones
  Companies Mentioned: PODD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/PODD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 10, 2024 14:55 ET (18:55 GMT)

May 22, 2024
- Repligen Insider Sold Shares Worth $3,377,283, According to a Recent SEC Filing, from 5:17PM ET on Wednesday May 22, 2024 by MT Newswires
  5:17PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: RGEN
May 20, 2024
- Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60, from 6:59AM ET on Monday May 20, 2024 by MT Newswires
  6:59AM ET on Monday May 20, 2024 by MT Newswires
  Companies Mentioned: GMED
May 16, 2024
- Johnson & Johnson to Buy Proteologix For $850 Million in Cash, from 1:41PM ET on Thursday May 16, 2024 by MT Newswires
  1:41PM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: JNJ, SWAV
May 14, 2024
- Globus Medical Insider Sold Shares Worth $4,090,022, According to a Recent SEC Filing, from 5:24PM ET on Tuesday May 14, 2024 by MT Newswires
  5:24PM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: GMED
May 13, 2024
- Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition, from 11:01AM ET on Monday May 13, 2024 by MT Newswires
  11:01AM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: JNJ, SWAV
- Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating, from 7:07AM ET on Monday May 13, 2024 by MT Newswires
  7:07AM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: GMED
- Teleflex Publishes 2023 Global Impact Report, from 6:30AM ET on Monday May 13, 2024 by GlobeNewswire
  6:30AM ET on Monday May 13, 2024 by GlobeNewswire
  Companies Mentioned: TFX
May 10, 2024
- Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing, from 4:52PM ET on Friday May 10, 2024 by MT Newswires
  4:52PM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: GMED
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGS, SWAV, HRT, from 9:51AM ET on Friday May 10, 2024 by GlobeNewswire
  9:51AM ET on Friday May 10, 2024 by GlobeNewswire
  Companies Mentioned: AGS, SWAV, HRT
May 9, 2024
- Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating, from 11:57AM ET on Thursday May 09, 2024 by MT Newswires
  11:57AM ET on Thursday May 09, 2024 by MT Newswires
  Companies Mentioned: GMED

Insulet Corp
NASDAQ:PODDUnited States

Search Criteria

Today

Insulet to Present at the Jefferies Global Healthcare Conference, from 5 hours ago by Business Wire

Insulet to Present at the Jefferies Global Healthcare Conference, from 5 hours ago by Dow Jones

May 14, 2024

Insulet Shares Rise Despite Blue Orca's Short Position, from 11:19AM ET on Tuesday May 14, 2024 by MT Newswires

May 13, 2024

DJ Insulet Is Maintained at Equal-Weight by Barclays, from 2:14PM ET on Monday May 13, 2024 by Dow Jones

May 10, 2024

DJ Insulet Is Maintained at Buy by Canaccord Genuity, from 2:55PM ET on Friday May 10, 2024 by Dow Jones

Peers Headlines

May 22, 2024

Repligen Insider Sold Shares Worth $3,377,283, According to a Recent SEC Filing, from 5:17PM ET on Wednesday May 22, 2024 by MT Newswires

May 20, 2024

Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60, from 6:59AM ET on Monday May 20, 2024 by MT Newswires

May 16, 2024

Johnson & Johnson to Buy Proteologix For $850 Million in Cash, from 1:41PM ET on Thursday May 16, 2024 by MT Newswires

May 14, 2024

Globus Medical Insider Sold Shares Worth $4,090,022, According to a Recent SEC Filing, from 5:24PM ET on Tuesday May 14, 2024 by MT Newswires

May 13, 2024

Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition, from 11:01AM ET on Monday May 13, 2024 by MT Newswires

Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating, from 7:07AM ET on Monday May 13, 2024 by MT Newswires

Teleflex Publishes 2023 Global Impact Report, from 6:30AM ET on Monday May 13, 2024 by GlobeNewswire

May 10, 2024

Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing, from 4:52PM ET on Friday May 10, 2024 by MT Newswires

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGS, SWAV, HRT, from 9:51AM ET on Friday May 10, 2024 by GlobeNewswire

May 9, 2024

Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating, from 11:57AM ET on Thursday May 09, 2024 by MT Newswires